Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wang, Chi Chung ^a   Lin, Sheng Yi ^b   Lai, Yi Hua ^b   Liu, Ya Jung ^a   Hsu, Yuan Lin ^a   Chen, Jeremy J W ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; PROTEIN HLJ1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PROMOTER REGION; TREATMENT RESPONSE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DIMETHYL SULFOXIDE; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP40 HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84859807190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033772     Document Type: Article

References (46)

1. Santos NC, Martins-Silva J, Saldanha C, (2005) PTEN "meets" DMSO. Leuk Res 29: 361-362.
2. Pegg DE, (2007) Principles of cryopreservation. Methods Mol Biol 368: 39-57.
3. Bertelli G, Gozza A, Forno GB, Vidili MG, Silvestro S, et al. (1995) Topical dimethyl sulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851-2855.
4. Morassi P, Massa F, Mesesnel E, Magris D, D'Agnolo B, (1989) Treatment of amyloidosis with dimethyl sulfoxide (DMSO). Minerva Med 80: 65-70.
5. Salim AS, (1992) Role of oxygen-derived free-radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. J Lab Clin Med 119: 710-717.
6. Salim AS, (1991) Protection against stress-induced acute gastric mucosal injury by free radical scavengers. Intensive Care Med 17: 455-60.
7. Ikeda Y, Long DM, (1990) Comparative effects of direct and indirect hydroxyl radical scavengers on traumatic brain edema. Acta Neurochir Suppl (Wien) 51: 74-76.
8. Rosenstein ED, (1999) Topical agents in the treatment of rheumatic disorders. Rheum Dis Clin North Am 25: 899-918.
9. Goto I, Yamamoto-Yamagushi Y, Honma Y, (1996) Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon-α by differentiation inducing agents. Br J Cancer 74: 546-554.
10. Murav'ev IV, (1986) Treatment of rheumatoid synovitis by intra-articular administration of dimethyl sulfoxide and corticosteroid. Ter Arkh 58: 104-105.
11. Smith RS, (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 39: 248-257.
12. Parkin J, Shea C, Sant GR, (1997) Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis - a practical approach. Urology 49: 105-107.
13. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C, (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65: 1035-1041.
14. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC, (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75: 2458-2462.
15. Kami D, Schiojima I, Makino H, Matsumoto K, Takahashi Y, et al. (2008) Gremlin enhances the determined path to cardiomyogenesis. PLoS ONE 3: e2407.
16. Takase K, Sawai M, Yamamoto K, Yata J, Takasaki Y, et al. (1992) Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells. Cell Growth Diff 3: 515-521.
17. Teraoka H, Mikoshiba M, Takase K, Yamamoto K, Tsukada K, (1996) Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells Exp Cell Res 222: 218-224.
18. Koizumi K, Tsutsumi Y, Yoshioka Y, Watanabe M, Okamoto T, et al. (2003) Anti-angiogenic effects of dimethyl sulfoxide on endothelial cells. Biol Pharm Bull 26: 1295-1298.
19. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, CA Cancer J Clin 58: 71-96.
20. Curado MP, Edwards B, Shin HR, eds. (2007) Cancer Incidence in Five Continents, Vol. IX. International Agency for Research on Cancer Lyon.
21. Chen JJW, Peck K, Hong TM, Yang SC, Sher YP, et al. (2001) Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61: 5223-5230.
22. Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, et al. (2006) A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with nonsmall-cell lung carcinoma. J Natl Cancer Inst 98: 825-838.
23. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, et al. (2005) The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 24: 4081-4093.
24. Wang CC, Tsai MF, Dai TH, Hong TM, Chan WK, et al. (2007) Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Cancer Res 67: 4816-4826.
25. Albini A, Pfeffer U, (2006) A new tumor suppressor gene: invasion, metastasis and angiogenesis as potential key targets. J Natl Cancer Inst 98: 825-838.
26. Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, et al. (2010) HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res 38: 6148-6158.
27. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, et al. (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68: 7428-7438.
28. Chang CK, Albarillo MV, Schumer W, (2001) Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of NF-κB and AP-1 in septic rats. J Surg Res 95: 181-187.
29. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunningshake GW, (1998) AP-1 is the preferred transcription factor for cooperative interaction with NF-κB in respiratory syncytial virus-induced IL-8 gene expression in airway epithelium. J Infect Dis 177: 1275-1281.
30. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360.
31. Chen JJW, Yao PL, Yuan A, Hong TM, Shun CT, et al. (2003) Up-regulation of tumor interlukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 9: 729-737.
32. Shirley SW, Stewart BH, Mirelman S, (1978) Dimethyl sulfoxide in the treatment of inflammatory genitourinary disorders. Urology 11: 215-220.
33. Metts JF, (2001) Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 64: 1199-1206.
34. Moldwin RM, Sant GR, (2002) Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45: 259-272.
35. Hanslick JL, Lau K, Noguchi KK, Olney JW, Zorumski CF, et al. (2009) Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis 34: 1-10.
36. Lee YR, Shim HJ, Yu HN, Song EK, Park J, et al. (2005) Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells. Leuk Res 29: 401-405.
37. Reddy SP, Mossman BT, (2002) Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am J Physiol Lung Cell Mol Physiol 283: L1161-1178.
38. Eter N, Spitznas M, (2002) DMSO mimics inhibitory effects of thalidomide on choriocapillary endothelial cell proliferation in culture. Br J Ophthalmol 86: 1303-1305.
39. Camici GG, Steffel J, Akhmedov A, Schafer N, Baldinger J, et al. (2006) Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 114: 1512-1521.
40. Antonarakis ES, Emadi A, (2010) Ruthenium-based chemotherapeutics: are they ready for prime time? Cancer Chemother Pharmacol 66: 1-9.
41. Bouma M, Nuijen B, Jansen MT, Sava G, Flaibani A, et al. (2002) A kinetic study of the chemical stability of the metastatic ruthenium complex NAMI-A. Int J Pharm 248: 239-246.
42. Bacac M, Hotze ACG, van der Schilden K, Haasnoot JG, Pacor S, et al. (2004) The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. J Inorg Biochem 98: 402-412.
43. Cerosaletti KM, Blieden TM, Harwell LW, Welsh KM, Frelinger JG, et al. (1990) Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection. Cell Immunol 127: 299-310.
44. Takenaga K, (1984) Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. Cancer Res 44: 1122-1127.
45. Liu J, Yoshikawa H, Nakajima Y, Tasaka K, (2001) Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells. Int Immunopharmacol 1: 63-74.
46. Vondrácek J, Soucek K, Sheard MA, Chramostová K, Andrysík Z, et al. (2006) Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization. Leuk Res 30: 81-89.